Officer sold ~$364K of Vertex Pharmaceuticals
Scheduled in advanceLoading…
Traded May 1, 2026 · Filed May 5, 2026
Vertex Pharmaceuticals's and Chief Legal Officer sold $469K of Vertex Pharmaceuticals shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$469,222
Shares × reported transaction price
78 days after results of Feb 12, 2026, 3 days before results of May 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $423.92 on May 1, 2026, 16% above its 52-week low and 15% below its high, after a 7% drop over the previous 30 trading days
52-week range $366.54 (Aug 8, 2025) to $501.15 (May 2, 2025), 43% of the way up, from 251 adjusted closes. 30 trading days earlier: $458.05 on Mar 19, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.9% | +1.2% | +4.8% |
| 30 days | +4.5% | +0.5% | +4.0% |
| 90 days | +11.9% | +5.1% | +6.8% |
Past results only. Not a forecast.
Officer sold ~$364K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$888K of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$15K of Vertex Pharmaceuticals
Scheduled in advance
